
Quality Improvement Methodology Optimizes Infliximab Levels in Pediatric Patients with Inflammatory Bowel Disease
Author(s) -
Jennifer Hellmann,
Renee K Etter,
Lee A. Denson,
Phillip Minar,
Denise M. Hill,
Dana M. H. Dykes,
Michael J. Rosen
Publication year - 2021
Publication title -
pediatric quality and safety
Language(s) - English
Resource type - Journals
ISSN - 2472-0054
DOI - 10.1097/pq9.0000000000000400
Subject(s) - infliximab , medicine , guideline , inflammatory bowel disease , quality management , drug , disease , physical therapy , pharmacology , management system , management , pathology , economics
Supplemental Digital Content is available in the text.